Mico BioMed Supplies COVID-19 Antibody Test Kits Worth 2.2 Billion KRW to Domestic Medical Institutions and Companies
[Asia Economy Reporter Lee Gwan-joo] MikobioMed announced on the 7th that it will supply COVID-19 antibody test kits worth 2.2 billion KRW to domestic medical institutions and companies.
MikobioMed added that it plans to first supply antibody test kits worth 1.6 billion KRW domestically, followed by an additional supply worth 600 million KRW.
The diagnostic kit supplied for professional use allows individuals to determine their COVID-19 infection history and antibody presence through blood samples collected from the fingertip, similar to a blood glucose meter, showing sensitivity over 90% and specificity over 99%.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Trump: "Talks in Final Stages," Iran Reviewing U.S. Proposal... Oil Prices Plunge 5% (Comprehensive)
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
A company representative stated, "Recently, nationwide antibody testing has been discussed as part of 'scientific quarantine.' Through this, we will actively lead efforts to enable more precise quarantine policies by focusing diagnostic and treatment capabilities on regions and age groups with relatively fewer antibody carriers."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
